Survivin promotes a glycolytic switch in CD4
Biological sciences
Immunology
Transcriptomics
Journal
iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038
Informations de publication
Date de publication:
22 Dec 2022
22 Dec 2022
Historique:
received:
22
07
2022
revised:
10
08
2022
accepted:
04
11
2022
entrez:
25
11
2022
pubmed:
26
11
2022
medline:
26
11
2022
Statut:
epublish
Résumé
In this study, we explore the role of nuclear survivin in maintaining the effector phenotype of IFNγ-producing T cells acting through the transcriptional control of glucose utilization. High expression of survivin in CD4
Identifiants
pubmed: 36425763
doi: 10.1016/j.isci.2022.105526
pii: S2589-0042(22)01798-9
pmc: PMC9678772
doi:
Types de publication
Journal Article
Langues
eng
Pagination
105526Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
The authors declare no competing interests.
Références
Database (Oxford). 2017 Jan 1;2017:
pubmed: 28605766
BMC Immunol. 2019 Aug 22;20(1):30
pubmed: 31438837
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Immunity. 2011 Dec 23;35(6):871-82
pubmed: 22195744
Blood. 2004 Jan 1;103(1):120-7
pubmed: 12969960
Cancer Res. 2007 Sep 1;67(17):8014-21
pubmed: 17804712
Front Immunol. 2021 Jun 07;12:669456
pubmed: 34163475
Autoimmun Rev. 2017 Aug;16(8):845-855
pubmed: 28564620
J Immunol. 2008 Jun 1;180(11):7240-8
pubmed: 18490723
Biochim Biophys Acta Mol Basis Dis. 2017 Mar;1863(3):663-673
pubmed: 27915033
Nat Commun. 2019 Apr 5;10(1):1582
pubmed: 30952843
Signal Transduct Target Ther. 2017 Nov 24;2:17044
pubmed: 29263928
J Exp Med. 2004 Jan 5;199(1):69-80
pubmed: 14699085
Cell Res. 2020 Aug;30(8):649-659
pubmed: 32709897
J Exp Med. 2013 Sep 23;210(10):2119-34
pubmed: 24043759
Nat Commun. 2017 Sep 22;8(1):624
pubmed: 28935892
Cell. 2013 Aug 1;154(3):651-63
pubmed: 23911327
EMBO Rep. 2006 Dec;7(12):1259-65
pubmed: 17099693
J Diabetes Res. 2019 Jul 28;2019:5451038
pubmed: 31467927
Science. 2016 Oct 28;354(6311):481-484
pubmed: 27708054
Curr Opin Immunol. 2014 Apr;27:60-74
pubmed: 24556090
Hum Mol Genet. 2009 Nov 1;18(21):4195-203
pubmed: 19648290
Ann Rheum Dis. 2013 May;72(5):776-80
pubmed: 23434571
J Immunother Cancer. 2015 May 19;3:20
pubmed: 25992291
J Leukoc Biol. 2015 Jan;97(1):135-45
pubmed: 25381389
Sci Transl Med. 2015 Feb 11;7(274):274ra18
pubmed: 25673763
Nat Med. 2015 Jan;21(1):55-61
pubmed: 25501905
PLoS Biol. 2020 Jun 30;18(6):e3000732
pubmed: 32603375
Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):4844-9
pubmed: 10220381
Rheumatology (Oxford). 2020 Oct 1;59(10):2816-2828
pubmed: 32047926
Mol Cell Proteomics. 2012 Jul;11(7):M111.013243
pubmed: 22442257
Nat Immunol. 2011 Sep 20;12(10):918-22
pubmed: 21934668
Nat Genet. 2002 Feb;30(2):221-6
pubmed: 11818964
Front Immunol. 2019 Jul 03;10:1462
pubmed: 31333642
Nat Commun. 2020 Dec 3;11(1):6196
pubmed: 33273453
Nature. 2014 Feb 20;506(7488):376-81
pubmed: 24390342
Immunity. 2017 May 16;46(5):714-729
pubmed: 28514673
Microb Pathog. 2009 Feb;46(2):88-97
pubmed: 19041714
Int J Biochem Mol Biol. 2012;3(2):179-97
pubmed: 22773958
J Immunol. 2008 Apr 1;180(7):4476-86
pubmed: 18354169
Nat Rev Mol Cell Biol. 2012 Dec;13(12):789-803
pubmed: 23175282
Nat Metab. 2022 Mar;4(3):389-403
pubmed: 35347316
Front Neurol. 2014 Dec 01;5:250
pubmed: 25520698
Adv Cancer Res. 2003;88:31-52
pubmed: 12665052
PLoS One. 2011;6(7):e21800
pubmed: 21789182
J Immunol. 2020 Oct 1;205(7):1743-1751
pubmed: 32839239
Trends Immunol. 2015 Feb;36(2):81-91
pubmed: 25592731
Oncotarget. 2015 Aug 21;6(24):20043-57
pubmed: 26343374
BMC Med. 2015 Sep 30;13:247
pubmed: 26420684
Nat Commun. 2021 Jan 18;12(1):420
pubmed: 33462242
Front Immunol. 2015 Oct 30;6:539
pubmed: 26579119
Hum Vaccin Immunother. 2015;11(7):1585-95
pubmed: 26042612
Ann Rheum Dis. 2022 Jun 9;:
pubmed: 35680389
Nat Commun. 2020 Sep 2;11(1):4402
pubmed: 32879318
Cancer Res. 2007 Apr 1;67(7):3441-9
pubmed: 17409455
J Immunol Methods. 2006 Apr 20;311(1-2):117-29
pubmed: 16563425
Lupus Sci Med. 2019 Aug 13;6(1):e000270
pubmed: 31497305
Immunol Med. 2020 Jun;43(2):72-78
pubmed: 32338187
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5240-5
pubmed: 12682297
Leukemia. 2015 Feb;29(2):433-40
pubmed: 24903482
Front Immunol. 2021 Aug 06;12:710904
pubmed: 34421916
Nucleic Acids Res. 2018 Jan 4;46(D1):D260-D266
pubmed: 29140473
Clin Rev Allergy Immunol. 2020 Oct;59(2):248-272
pubmed: 32557263
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Eur J Immunol. 2013 Nov;43(11):2797-809
pubmed: 24258910
PLoS One. 2010 Nov 22;5(11):e14076
pubmed: 21124930
Science. 2021 Jan 22;371(6527):405-410
pubmed: 33479154
Cell Metab. 2014 Jul 1;20(1):61-72
pubmed: 24930970
RNA. 2017 Jul;23(7):1125-1138
pubmed: 28411202
Nat Immunol. 2013 Oct;14(10):1064-72
pubmed: 23955661
Nat Immunol. 2019 Dec;20(12):1574-1583
pubmed: 31745335
Arthritis Res Ther. 2014 Jan 16;16(1):R12
pubmed: 24428870
Sci Adv. 2021 Jan 6;7(2):
pubmed: 33523973
Leuk Res. 2009 Dec;33(12):1627-35
pubmed: 19286254
J Exp Med. 2004 Feb 2;199(3):399-410
pubmed: 14757745
Nature. 2017 Feb 23;542(7642):479-483
pubmed: 28192788
Clin Cancer Res. 2008 Oct 15;14(20):6496-504
pubmed: 18927289
Exp Cell Res. 2002 Apr 15;275(1):44-53
pubmed: 11925104
Diabetes Care. 2018 Nov;41(11):2396-2403
pubmed: 30254083
Arthritis Rheum. 2005 May;52(5):1534-44
pubmed: 15880807
Sci Rep. 2018 Jul 6;8(1):10289
pubmed: 29980758
J Exp Med. 2003 Mar 17;197(6):711-23
pubmed: 12642603